Notice2022-01949
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-CE-22-001, Grants To Support New Investigators in Conducting Research Related to Understanding Polydrug Use Risk and Protective Factors; Cancellation of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 1, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 21 (Tuesday, February 1, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 21 (Tuesday, February 1, 2022)]
[Notices]
[Page 5483]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-01949]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP)--RFA-CE-22-001, Grants To Support New
Investigators in Conducting Research Related to Understanding Polydrug
Use Risk and Protective Factors; Cancellation of Meeting
AGENCY: Centers for Disease Control and Prevention, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the
meeting of the Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP)--RFA-CE-22-001, Grants to Support New
Investigators in Conducting Research Related to Understanding Polydrug
Use Risk and Protective Factors; March 15-16, 2022, 8:30 a.m.-5:30
p.m., EDT. The web conference was published in the Federal Register on
January 5, 2022, Volume 87, Number 3, page 460.
This meeting is being canceled in its entirety.
FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific
Review Officer, National Center for Injury Prevention and Control, CDC,
4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341-3717,
Telephone: (404) 639-6473, Email: <a href="/cdn-cgi/l/email-protection#3273655b5e595741725156511c555d44"><span class="__cf_email__" data-cfemail="4203152b2e292731022126216c252d34">[email protected]</span></a>.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-01949 Filed 1-31-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 1, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.